The serum TNF-α and IL-6 levels in the NAFLD group decreased after drug intervention [37], while in the GXZY-NASH and GXZY-fibrosis groups, SOD levels increased, MDA expression decreased, and the oxidative stress response was inhibited. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.